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Background: Bovine herpesvirus 4 (BoHV-4) is a gammaherpesvirus, belonging to Rhadinovirus genus, with no
clear association with disease. However, there is increasing evidence of its secondary pathogenic role in cases of
post-partum metritis in cattle. BoHV-4 Open Reading Frame 8 (ORF8) codifies for glycoprotein B (gB) that shows a
heterodimeric structure, composed of two subunits and covalently linked by disulfide bonds and responsible for
host cell adhesion through binding to heparan sulfates associated with cellular proteoglycans. Here we describe the
generation of several tagged soluble forms of gB ectodomain, in order to test their ability to neutralize BoHV-4
infection.
Results: The results show, however, that none of these soluble forms are able to block viral infectivity. To better
understand the role of gB during BoHV-4 lytic replication, a recombinant BoHV-4 was generated by homologous
recombination from a BoHV-4 cloned as a Bacterial artificial chromosome (BAC) (pBAC-BoHV-4-A), in which most of
the BoHV-4 gB ORF was substituted by the insertion of a DNA stuffer selectable cassette. The resulting recombinant
BoHV-4 genome (pBAC-BoHV-4-AΔgB-KanaGalK) was completely unable to reconstitute infectious replicating viral
particles (Infectious Replicating Viral Particles, IRVPs) and to replicate when transfected in permissive cell lines in
comparison to its revertant clone (pBAC-BoHV-4-ΔgB-Rev) or pBAC-BoHV-4-A parental clone.
Conclusion: This demonstrates that the BoHV-4 replicating cycle is dependent on gB. Moreover, when gB was
deleted from a recombinant BoHV-4 genome delivering an heterologous glycoprotein, Vesicular Stomatitis Virus
Glycoprotein (VSVg), VSVg was unable to complement gB. This study provides direct evidence that gB is necessary
for BoHV-4 lytic replication.
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virus glycoproteinBackground
The Herpesvirus envelope contains a variable number of
glycoproteins involved in virus attachment, penetration,
budding and spreading among infected cells. Some of
these proteins are extremely conserved in functions and
sequences, while others are typical of a peculiar virus
genus or species.
The entry model mechanism of Human Herpes Virus
1 (HHV-1) is based firstly on the interaction between
glycoproteins gC and gB and the host cell heparan* Correspondence: gaetano.donofrio@unipr.it
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distribution, and reproduction in any mediumsulfates associated with glycosaminoglycans (GAGs) and
secondly, by gD-mediated penetration that is also
responsible for the fusion via gB, gH and gL [1]. Five gly-
coproteins are conserved in all herpesviruses, gB, gH,
gL, gM and gN, and numerous studies have been carried
out in order to characterize them [2].
The gB gene is one of the most conserved glycopro-
teins among the herpesvirus family. Homologues of gB
have in fact been identified in every human and animal
herpesvirus studied [3]. The hypothesis that gB function
may be conserved in all herpesviruses is corroborated by
its secondary structure, that shows the consistent con-
servation of cysteine and proline residues and the
carboxy-terminal portion of the proteins [3].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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virus, Rhadinovirus genus, and has been isolated world-
wide both in healthy animals and in animals with a
range of diseases varying from ocular discharge, con-
junctivitis, dermatitis, respiratory diseases and abortion
[4]. The pathogenic role of BoHV-4 is still unclear, even
if there is increasing evidence of a secondary pathogenic
role in bovine post-partum metritis [5,6].
Ten glycoproteins have been identified in BoHV-4 [7]
and gB was demonstrated to be involved in cell host con-
tact through heparan sulfate interactions [8]. It is not
known if this interaction is sufficient to induce virus
penetration and fusion or if a cellular receptor is specifi-
cally required, as for example occurs for Human Herpes-
virus 5 (HHV-5) [9]. Structurally, gB is a heterodimeric
protein, composed of two subunits linked by disulfide
bonds. The protein is derived from a precursor that is
first glycosylated, then trimmed and cleaved to acquire
the mature gB form, thanks to a putative cleavage site
which is present nearly in the middle of the sequence
[3,10]. Similarly to Human Herpesvirus 4 (HHV-4), Murid
Herpesvirus 4 (MuHV-4), Human Herpesvirus 8 (HHV-8)
and HHV-5 [10], gB is one of the major components of
the BoHV-4 virion. However the direct role of BoHV-4
gB for the progression of the virus into the lytic cycle has
yet to be demonstrated. In the present study, the gene-
ration of several tagged soluble forms of BoHV-4 gB ecto-
domain was described, and their inability to block viral
infectivity was also assessed. The cloning of different
isolates of BoHV-4 genome as Bacterial artificial chromo-
somes (BAC) [11-13] allowed the generation of a gB-
deleted mutant BoHV-4, which provided further evidence
that BoHV-4 gB has an indispensable role in BoHV-4 lytic
replication; moreover VSVg was unable to complement
BoHV-4 gB deletion, underlying the primary role of gB
during BoHV-4 life cycle.
Methods
DNA preparation and PCR
Virus infected cells were lysed overnight in Proteinase K
Buffer containing 10 mM Tris–HCl, pH 7.5, 1 mM
EDTA, 0.5% sodium dodecyl sulfate (SDS) and 100 μg of
proteinase K per ml at 37°C. Nucleic acids were extracted
by treatment with phenol–chloroform and precipitated
with ethanol. Treatment with 100 μg/ml of RNAse A
(Sigma) was performed for 1 h, after which the DNA was
extracted with phenol and precipitated with ethanol
again. The samples were kept at −20°C. One microgram
of DNA sample was amplified over 35 cycles, each cycle
consisting of denaturation at 94°C for 1 min, primer
annealing at 55°C for 1 min, and chain elongation with 1
U of Pfu DNA polymerase (Fermentas) at 72°C for 2 min.
PCR amplification was carried out in a final volume of 50
μl of 10 mM Tris–hydrochloride pH 8.3 containing 0.2mM deoxynucleotide triphosphates, 3 mM MgCl2, 50
mM KCl, 5% DMSO and 0.25 μM of each primer. The
primers used for the amplification of BoHV-4 ORF8,
coding for gB protein, are SgfI-gB-sense and MluI-gB-
antisense (see Table 1). The so generated 2185 bp ampli-
con was then checked in 1% agarose gel and visualized
after ethidium bromide staining in 1× TAE buffer
(40 mM Tris-acetate, 1 mM EDTA) and used to subclone
gB in an expression cassette. The specificity of the PCR
product was determined by sequencing.Plasmids
To generate pgBFc, BoHV-4 gB ORF (from 1–2175 nt)
was amplified by PCR using SgfI-gB-sense and MluI-gB-
antisense primer (see Table 1), cut with SgfI/MluI and
inserted in pCMV6-AC-Fc (OriGene) cut with the same
enzymes. gB/Fc ORF was cut from pgB/Fc firstly with
BamHI, blunt-ended, consequently cut with PmeI and
then sub-cloned in pWPI (Addgene; http://www.addgene.
org/12254/) cut with PmeI. Thus pWPI/gBFc was
obtained.
The chimeric ORF (1510 bp) coding for gBtruncated-
gD106 was obtained by gene synthesis (Eurofins MWG
Operon) where an NheI and a BamHI restriction sites
were included to the 50 and 30 end respectively. This
gBtruncatedgD106 ORF was excised from the vector
(pBluescript) by NheI/BamHI digestion and inserted in
pEGFP-C1 (Clontech) depleted of Green Fluorescent
Protein (GFP) after cutting with the same enzymes and
pCMV-gBtruncatedgD106 was obtained. Murine Fc was
then amplified by PCR from pCMV6-AC-Fc vector with
SalI-Fc-sense and BamHI-Fc-antisense primers (see
Table 1) and used to substitute the gD106 tag in pCMV-
gBtruncatedgD106.
pCMV-gBtruncated-gD106 was then cut with NdeI and
SalI and the gBtruncated was exchanged with the full
length 2614 bp gB ectodomain, excised from pgB/Fc, cut
with NdeI and XhoI. SalI and XhoI are compatible
enzymes and the generated ends are in frame. The so
generated pCMVgBgD106 was then cut with BamHI,
blunt-ended and the fusion peptide gBgD106 was inserted
in pWPI opened with PmeI and pWPI/gBgD106was
generated.
pBluescript/gBtruncatedgD106 was cut with NheI and
BamHI, the fragment was blunt-ended and inserted in
PmeI cut pWPI to generate pWPI/gBtruncatedgD106.
pCMV-gBtruncatedgD106 was cut with SalI/BamHI to
excise gD106 that was replaced with the 752bp SalI/
BamHI cut murine Fc amplicon for generating pCMV-
gBtruncatedFc.
The gBtruncatedFc was at the end excised from pCMV-
gBtruncatedFc, cut with NheI/BamHI, blunt-ended and
inserted in PmeI cut pWPI to obtain pWPI/gBtruncatedFc.
Table 1 List of primers used in this work
Primer name Primer sequence 50-30
SgfI-gB-sense 50-CCC CCC GCG ATC GCA TGT ATT ATA AGA CTA TCT TAT TCT TCG CT-30
MluI-gB-antisense 50-CCC CCC ACG CGT AAG GTC TGC CAT CAT TTC AGA GAG ATC TTT-30
SalI-Fc-sense 50-CCC GTC GAC CGT ACG CGG CCG CTC GAG ATG CCC AGA-30
BamHI-Fc-antisense 50-CCC GGA TCC GCG GCC GGC CGT TTA AAC TCA TTT ACC CGG-30
gB-left-sense 50-CCG GAA TTC AGA ACC CAC ACT ATA GGG GAA ACG ACC TCA-30
gB-left-antisense 50-TCT CCA GAG GAA GAT GAT GCA CTG CAT ACT CTG-30
gB-right-sense 50-CCCC CTG CAG TCA CAT CCT AGA GGA ATT AAC-30
gB-right-antisense 50-AGA CTT GCA AGC TTC TGT GTG TAG TAA TTA-30
SmaI-AseI-Kana-sense 50-AAC CCC CGG GAT TAA TCC GGA ATT GCC AGC TGG GG-30
SmaI-MluI-Kana anti 50-CCA ACC CGG GAC GCG TGA AAT TGT AAG CGT TAA TAA T-30
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2232 bp galactokinase prokaryotic expression cassette
(GalK), along with the kanamycin resistant expression
cassette (Kana), into the pTZ57R shuttle vector, cut with
KpnI/PstI [14]. The targeting vector, pgB-KanaGalK-gB,
was generated firstly by the insertion of the 1167bp left
gB homology region amplicon (gB-left-sense and anti-
sense, see Table 1) cut with EcoRI/KpnI, in pTZ-Kana-
GalK, cut with the same enzymes; in this intermediate
construct, cut with PstI/HindIII, was consequently sub-
cloned the 600bp right gB homology region amplicon
(gB-right-sense and antisense; see Table 1), cut with the
same enzymes.
Cells, cell culture electroporation and recombinant virus
reconstitution
Bovine Embryo Kidney [(BEK) from M. Ferrari, Istituto
Zooprofilattico Sperimentale, Brescia, Italy], MDBK
(Madin Darby Bovine Kidney cells), BEK/cre [12], HEK
(Human Embryo Kydney) and BESC (Bovine endomet-
rial stromal cells) cell lines were cultured in Dulbecco’s
modified Eagle Minimal Essential Medium (DMEM)
(Lonza) containing 10% fetal bovine serum (FBS), 2 mM
l-glutamine, 100 IU/ml penicillin (SIGMA) and 100 μg/
ml streptomycin (SIGMA).
Cells were sub cultured to a fresh culture vessel when
growth reached 70 to 90% confluence (i.e., every 3 to 5
days) and were incubated at 37°C in a humidified atmos-
phere of 95% air–5% CO2.
Plasmid DNAs (5 μg) in 500 μl DMEM without serum
were electroporated (Equibio apparatus, 270 V, 960 μF,
4-mm gap cuvettes) into BEK or BEK/cre cells from a
confluent 25-cm2 flask. Electroporated cells were then
returned to the flask, fed the next day, and split 1:2
when they reached confluence at 2 days post electropo-
ration. Cells were left to grow until Cytophatic Effect
(CPE) appeared. Recombinant viruses were propagated
by infecting confluent monolayers of MDBK cells at a
multiplicity of infection (m.o.i.) of 0.5 50% tissue cultureinfectious doses (TCID50) per cell and maintaining them
in MEM with 10% FBS for 2 h. The medium was
removed and replaced by fresh MEM containing 10%
FBS. When approximately 90% of the cell monolayer
exhibited CPE (~72 h post infection), the virus was
prepared by freezing and thawing cells three times and
pelleting virions through 30% sucrose, as described pre-
viously [12]. Virus pellets were resuspended in cold
MEM without FBS. TCID50 were determined on MDBK
or BEK cells by limiting dilution.
Viruses
BoHV-4-A, BoHV-4-A-ΔTK-EGFP, BAC-BoHV-4-A, BAC-
BoHV-4-AΔL1.7VSVG, BAC-BoHV-4-AΔL1.7VSVGΔgB-
KanaGalK, and BAC-BoHV-4-A-ΔgB-KanaGalK were pro-
pagated by infecting confluent monolayers of MDBK or
BEK cells at a m.o.i. of 0.5 and maintained in minimal
essential medium (MEM) (SIGMA) with 2% FBS for 2 h.
The medium was then removed and replaced by fresh
MEM containing 10% FBS. When approximately 90% of
the cell monolayer exhibited CPE (approximately 72 h post
infection), the virus was prepared by freezing and thawing
cells three times and pelleting the virions through 30%
sucrose, as previously described [12]. Virus pellets were
resuspended in cold MEM without FBS. TCID50 were
determined in MDBK cells by limiting dilution.
In vitro neutralization assay (NTA)
HEK cells were seeded in a 175 cm2 flask and when
reached the 85% of confluence, were transiently transfected
with the plasmids carrying the gB tagged constructs.
In particular, 14 ml of DMEM without serum were
incubated with 43,75 μl of LTX Lipofectamine (Invitro-
gen) and 17,5 μg of pWPI/gBFc, pWPI/gBtruncatedFc, or
pWPI/gBtruncatedgD106 at room temperature for at least
15 minutes. This transfection solution was then added
carefully to the HEK cell monolayer and left to incubate
6 hours at 37°C with 5% CO2. The transfection solution
was then removed and replaced by 21 ml of 1:1 DMEM/
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any traces of the transfection solution. After 96 hours
the supernatant was collected, clarified at 3000 r.p.m. for
5 minutes and stored at −20°C.
The expression of gB was assessed by Western Blo-
tting ( the amount of gB was estimated to be between 5
and 50 μg/ml, depending on the preparation) and conse-
quently the supernatant was used for the neutralization
assay.
105 HEK cells/well were seeded in a 12 multiwells
plate and left to attach to the well.
After few hours the cells were pre-incubated 30 mi-
nutes at 37°C with 1ml/well of the supernatant recov-
ered from HEK transfected with pWPI/gBFc or pWPI/
gBtruncatedgD106 or pWPI/gBtruncatedFc with medium
without serum. The supernatant was then removed and
substituted with ten-fold BoHV-4-A-ΔTK-EGFP virus
dilution, starting from 1 to 10-3 m.o.i. The cells were
then incubated overnight at 37°C in 5% humidified
atmosphere.
This assay was also repeated in BESC cells, with the
same protocol, but seeding 3×103 cells/well in a 96
multiwell plate; the cells were then treated with the gB
supernatant and infected with two-fold dilutions of the
virus, starting from 10 m.o.i.
These two protocols were also tested using a contact
time varying from 30 to 60 minutes and/or an incuba-
tion contact temperature of 4°C or 37°C.
The virus spreading was then monitored during the
following days by fluorescence and contrast microscope
analysis.
Recombineering and selection
Recombineering was performed as previously described
[15] with some modifications. Five hundred μl of a 32°C
overnight culture of SW102 containing BAC-BoHV-4-A,
and BAC-BoHV-4-AΔL1.7-VSVG were diluted in 25 ml
Luria–Bertani (LB) medium with or without chloram-
phenicol (SIGMA) selection (12.5 μg/ml) in a 50 ml
baffled conical flask and grown at 32°C in a shaking
water bath to an OD600 of 0.6. Then, 12 ml were trans-
ferred to another baffled 50 ml conical flask and heat-
shocked at 42°C for exactly 15 minutes in a shaking
water bath. The remaining culture was left at 32°C as
the un-induced control. After 15 minutes the two sam-
ples, induced and un-induced, were briefly cooled in ice/
water bath slurry and then transferred to two 15 ml
Falcon tubes and pelleted using 5000 r.p.m. (Eppendorf
centrifuge) at 0°C for 5 min. The supernatant was
poured off and the pellet was resuspended in 1 ml ice-
cold ddH2O by gently swirling the tubes in ice/water
bath slurry. Subsequently, 9 ml ice-cold ddH2O was
added and the samples pelleted again. This step was
repeated once more, the supernatant was removed andthe pellet (50 μl each) was kept on ice until electropo-
rated with gel-purified ~3.8 kb fragment (gB-KanaGalK-
gB) obtained by cutting pgB-KanaGalK-gB with EcoRI/
HindIII (Fermentas). An aliquot of 25 μl was used for
each electroporation in a 0.1 cm cuvette at 25 μF, 2.5 kV
and 201 Ω. After electroporation, the bacteria were
recovered in 1 ml LB (15 ml Falcon tube) for 1 hour in a
32°C shaking water bath. For the counter selection step
(see below), the bacteria were recovered in 10 ml LB in
a 50 ml baffled conical flask and incubated for 4.5 hours
in a 32°C shaking water bath.
After the recovery period, bacteria were washed twice
in sterile 1x M9 salts (6 g/l Na2HPO4, 3 g/l KH2PO4,
1 g/l NH4Cl , 0.5 g/l NaCl,) (SIGMA) as follows: 1 ml
culture was pelleted in an eppendorf tube at 13,200 r.p.m.
for 15 seconds and the supernatant was removed with a
pipette. The pellet was resuspended in 1 ml of 1× M9
salts, and pelleted again. This washing step was repeated
once more. After the second wash, the supernatant was
removed and the pellet was resuspended in 1 ml of 1×
M9 salts before plating serial dilutions (100 μl each of
1:10, 1:100 and 1:1000 dilutions) on M63 minimal
medium plates [15 g/l agar (DIFCO, BD Biosciences),
0.2% D-galactose (SIGMA), 1 mg/l D-biotin (SIGMA),
45 mg/l L-leucine (SIGMA) and 50 mg/l kanamycin
(SIGMA)]. Washing in M9 salts is necessary to remove
any rich media from the bacteria prior to selection on
minimal medium plates. Plates were incubated 3–5 days
at 32°C. Several selected colonies were picked, streaked
on McConkey agar indicator plates (DIFCO, BD Bios-
ciences) containing 50 μg/ml of kanamycin and incubated
at 32°C for 3 days until red colonies appeared. Red col-
onies were grown overnight in 5 ml of LB containing
50 μg/ml of kanamycin and BAC-BoHV-4-AΔgB-
KanaGalK were purified and analysed trough HindIII re-
striction enzyme digestion for gB-KanaGalK-gB fragment
targeted integration into the BoHV-4-A gB locus.
SW102 bacteria containing BAC-BoHV-4-AΔgB-Kana-
GalK genome were also grown, heat induced as described
above and electroporated with a ~2.9kb gel purified frag-
ment (gBlocus) obtained by amplifying the gB locus with
the primers gB-left-sense and gB-right-antisense. For the
counter selection step, the bacteria were recovered in 10
ml LB in a 50 ml baffled conical flask and incubated for
4.5 hours in a 32°C shaking water bath. Bacterial serial
dilutions were plated on M63 minimal medium plates
containing 15 g/l agar, 0.2% glycerol (SIGMA), 1 mg/l
D-biotin, 45 mg/l L-leucine, 0.2% 2-deoxy-galactose
(DOG, SIGMA) and 12.5 μg/ml chloramphenicol. Plates
were incubated for 3–5 days at 32°C. Several selected co-
lonies were picked up, streaked on McConkey agar indi-
cator plates (DIFCO, BD Biosciences) containing 12.5 μg/
ml of chloramphenicol and incubated at 32°C for 3 days
until white colonies appeared. White colonies were grown
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μg/ml of kanamycin or LB containing 12.5 μg/ml of
chloramphenicol. Only those colonies growing on chlo-
ramphenicol and not on kanamycin were kept and grown
overnight in 5 ml of LB containing 12.5 μg/ml of chlo-
ramphenicol. BAC-BoHV-4-gBrevertant was purified and
analysed through HindIII restriction enzyme digestion for
gB locus fragment targeted integration. Original detailed
protocols for recombineering can also be found at the
recombineering website [16].
Restriction enzyme analysis and non isotopic Southern
hybridization
Fifteen μl of DNA prepared from bacteria containing
pBAC-BoHV-4-A and derivatives were restriction enzyme-
digested with HindIII, separated by electrophoresis over-
night in a 0.8% agarose gel, stained with ethidium bromide,
capillary transferred to a positively charged nylon mem-
brane (Roche), and cross-linked by UV irradiation by
standard procedures. The membrane was pre-hybridized in
50 ml of hybridization solution (7% SDS, 0.5 M phosphate,
pH 7.2, 1 mM EDTA) for 2 hours at 65°C in a rotating
hybridization oven (Techna instruments). Probe prepar-
ation and digoxigenin non-isotopic labelling was per-
formed by PCR.
Southern Blotting probe was designed spanning Kana
region using the primer pair SmaI-AseI-Kana sense and
SmaI-MluI-Kana anti (see Table 1).
PCR amplification was carried out in a final volume of
50 μl of 10 mM Tris–HCl, pH 8.3, containing 0.2 mM
deoxynucleotide triphosphates, 0.02 mM alkaline labile
digoxigenin-dUTP (Roche), 3 mM MgCl2, 50 mM KCl,
and 0.25 μM of each primer over 35 cycles, each cycle
consisting of denaturation at 94°C for 1 minute, primer
annealing at 55°C for 1 minute, and chain elongation with
1 U of Taq polymerase (Boehringer Diagnostics) at 72°C
for 1 minute. A parallel reaction omitting digoxigenin-
dUTP was performed, because digoxigenin incorporation
into the amplicon can be checked through the size shift
of the amplicon by gel electrophoresis. Five μl of the
probe were added to 100 μl of ddH2O into a screw-cap
tube, denatured in boiling water for 5 minutes, and cooled
down on ice for another 2 minutes. Denatured probe was
added to 50 ml of pre-heated 65°C hybridization solution
to the pre-hybridized membrane and hybridized overnight
at 65°C in a rotating hybridization oven (Techna Instru-
ments). Following hybridization, the membrane was
washed twice for 30 minutes with 100 ml of washing solu-
tion I (0.5× SSC [1× SSC is 0.15 M NaCl plus 0.015 M
sodium citrate] and 0.1% SDS) and twice for 30 minutes
with 100 ml of washing solution II (40 mM phosphate,
pH 7.2, 0.05% SDS) at 65°C. On a freshly washed dish, the
membrane was incubated for 30 min at room temperature
in 25 ml of blocking solution (100 mM maleic acid, pH7.5, 150 mM NaCl, 1% blocking reagent [Roche] or 5%
skim milk). Anti-digoxigenin Fab fragment (150 U/200 μl
[Roche]), diluted 1:15,000 in 25 ml of blocking solution,
was applied to the membrane for 30 minutes under gentle
shaking at room temperature and washed twice for 15
minutes with 100 ml of washing solution (100 mM maleic
acid, pH 7.5, 150 mM NaCl, 0.3% Tween 20). Detection
was performed following equilibration of the membrane
in detection buffer (100 mM Tris–HCl, pH 9.5, 1 mM
EDTA) for 2 minutes at room temperature. Chemilumi-
nescent substrate (CSPD, Roche) was added by scattering
the drops over the surface of the membrane after place-
ment of the membrane between two plastic sheets, and
any bubbles present under the sheet were eliminated with
a damp lab tissue to create a liquid seal around the
membrane. Signal detection was obtained, exposing the
membrane to X-ray film. The exposure time was adjusted
with the intensity of the signal.
Western immunoblotting
Cell lysates containing 50 μg of total protein were electro-
phoresed through 8 to 12% SDS-polyacrylamide gels and
transferred to nylon membranes by electro blotting.
Membranes were incubated with monoclonal anti-BoHV-
1-gD antibody (clone 1B8F11; VRMD, Inc., Pullman,
WA), probed with horseradish peroxidase-labelled anti-
mouse immunoglobulin G (IgG) antibody (SIGMA), and
visualized by enhanced chemiluminescence (Millipore).
For detecting the Fc was used an anti-mouse IgG whole
molecule (A9044, Sigma, Saint Louis, Missouri).
Results and discussion
Soluble gB fragments did not inhibit virus attachment
and replication
Recent studies have demonstrated that HHV-4 infection
can be prevented by treating cells with a library of pep-
tides homologous to the ectodomain of the HHV-4 gB.
[9]. To verify if BoHV-4 gB could act as a soluble ligand
for a putative BoHV-4 host cell receptor and block
BoHV-4 infection, BoHV-4 gB ectodomain was sub-
cloned and expressed as a secreted form into the super-
natant of transiently transfected cells. BoHV-4 gB has a
length of 873 aa and corresponds to an ORF of 2622 bp
(Figure 1A and B). Several studies have demonstrated
that the mature form of gB is heterodimeric and is ge-
nerated by the presence of an internal putative proteasic
site (RQKRS) in the second half of its aminoacidic
sequence that is responsible for the cleavage of the two
subunits, that are then covalently linked by disulfide
bonds (Figure 1B) [3,10].
The secreted forms of gB were obtained on the basis
of its transmembrane domain and cytoplasmic tail exclu-
sion and/or substitution. Firstly, the full gB ectodomain
(720 aa) was fused to a murine Fc tag encoding the
Figure 1 BoHV-4 gB constructs design. A) Schematic representation (not to scale) of BoHV-4 gB ORF; in grey is represented the putative
protease site and in red the transmembrane domain. B) BoHV-4 gB annotated sequence with deduced amino acidic sequence, from the ATG to
stop site. In grey is underlined the putative protease site (RQKRS) and in red the transmembrane domain. C) Diagram (not to scale) showing the
pWPI/gBFc vector containing: the human elongation factor 1α (PeF1 α) promoter, the chimeric gB ORF ectodomain (gB) (1-720aa), the protease
site is evidenced in grey, fused with the murine Fc (in sky blue), then an IRES and the EGFP ORF (in green). Diagram (not to scale) showing the
pWPI/gBtruncatedFc vector containing: the human elongation factor 1α (PeF1 α) promoter, the chimeric gB ORF ectodomain (1-420aa), fused with
the murine Fc (in sky blue), then an IRES and the EGFP ORF. Diagram (not to scale) showing the pWPI/gBgD106 vector containing: the human
elongation factor 1α (PeF1 α) promoter, the chimeric gB ORF ectodomain (1-720aa), the protease site is evidenced in grey, fused with the gD106
tag (in yellow), then an IRES and the EGFP ORF. Diagram (not to scale) showing the pWPI/gBtruncated-gD106 vector containing: the human
elongation factor 1α (PeF1 α) promoter, the chimeric gB ORF ectodomain (1-420aa), fused with the gD106 tag (in yellow), then an IRES and the
EGFP ORF.
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mouse IgG heavy chain, in order to generate gBFc
(Figure 1B and Additional file 1: Figure S1A). Thus, gBFc
ORF was inserted into the pWPI vector [17] and pWPI/
gBFc was obtained (Figure 1B). In pWPI/gBFc, the expres-
sion of gBFc is under the control of the human elongation
factor 1α promoter (EF1α). Downstream to the gBFc ORF,
an internal ribosomal entry site (IRES), the GFP ORF and
a Simian Virus 40 (SV40) large T antigen polyadenylation
signal (pA) were also present (Figure 1B). This polycistro-
nic construct allowed the rapid monitoring of the func-
tionality of the construct by direct visualization of GFP
expression by fluorescence microscopy (Additional file 1:
Figure S1B). gBFc was correctly expressed, secreted andpost-translationally modified when pWPI/gBFc was transi-
ently transfected into HEK cells (Figure 2A and B). In fact,
the variation of its size observed in western immunoblot-
ting, was appreciable when the supernatant or protein cell
extract from pWPI/gBFc transiently transfected cells were
treated or untreated with reducing agents such as dithio-
threitol (DTT) or β-mercaptoethanol (Figure 2A and B).
A truncated form of gB fused to Fc was also generated,
gBtruncated/Fc (Figure 1B and Additional file 2: Figure S2A),
where only a part of the gB ectodomain (first 460 aa) was
fused to Fc. Also in this case, gBtruncatedFc was correctly
expressed, secreted and post-translationally modified when
pWPI/gBtruncatedFc was transiently transfected into HEK
cells (Figure 2B). Two other versions of gB, gBgD106 and
Figure 2 BoHV-4 gB chimeric peptide expression. A) Western
Immunoblotting of pWPI/gBFc transfected HEK293 cell lysate or
supernatant, in presence or absence of a reducing agent, β-
mercaptoethanol. The cell extract of pEGFP-C1 transfected HEK 293
was used as a negative control. As a positive control, the
supernatant of cells transfected with a plasmid carrying only the
murine Fc was used. B) Western Immunoblotting of pWPI/gBFc and
pWPI/gBtruncatedFc transfected HEK293 cell lysates with the presence
of β-mercaptoethanol. C) Western Immunoblotting of pWPI/gBgD106
and pWPI/gBtruncatedgD106 transfected HEK293 cell lysates and
supernatant . The control used was the same of the Figure 2A.
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Fc tag with the gD106 soluble epitope tag of BoHV-1 in
order to verify the influence of the tag peptide fused with
gB in terms of secretion (Figure 2B and Additional file 3:
Figure S3 and Additional file 4: Figure S4).
Surprisingly, only gBtruncatedgD106 was efficiently secreted
in transiently transfected HEK cells, as shown in
Figure 2B and C. Although gBgD106 was well expressed,
its secretion levels were very low. It was outside the scope
of the present work to determine the reasons of the inabi-
lity of gBgD106 to be efficiently secreted and gBgD106 was
eliminated from the study.
The supernatants containing gBFc, gBtruncatedFc and
gBtruncatedD106 were used in an in vitro neutralization
assay (NTA) to verify if one of these secreted forms
could successfully prevent BoHV-4 attachment and
penetration. The NTA was performed on different cell
lines (HEK, BEK, MDBK and BESC), employing a re-
combinant BoHV-4 expressing GFP (BoHV-4EGFPΔTK)
[18], at different temperatures (37 and 4°C), time of con-
tact (30 and 60 minutes), number of seeded cells and
amount of secreted peptides. BoHV-4 attachment and
penetration was monitored at different times (24 and 48
hours) by GFP expression under fluorescence micros-
copy. No blocking activity was achieved with any of the
experimental conditions tested (Figure 3 and data not
shown). The secreted gB forms tested were apparently
unable to prevent BoHV-4 attachment and penetration
and this was in contrast with that reported for some
Herpesvirus [19], but in agreement with others [20].
The inability of gBFc, gBtruncatedFc and gBtrunca-
tedgD106 to prevent BoHV-4 attachment and penetra-
tion of the host cell gave rise to several hypothesis: a)
the folding of the secreted peptide could be improper; b)
the amount of the secreted peptide could be insufficient;
c) viral glycoproteins different from gB could be respon-
sible for mediating virus-cell interaction and internaliza-
tion, subordinating gB to a secondary role.
BoHV-4-AΔgB was unable to replicate in host cells
Therefore, it was of interest to investigate the above hy-
potheses through the disruption of the gB gene in BoHV-
4 genome. The BoHV-4 gB ORF was disrupted by site
Figure 3 Secreted gB neutralization assay. Representative fluorescence and phase contrast images (10X) of MDBK cells untreated A) or treated
B) for 1 hour at 37°C with BoHV-4 gB enriched supernatant and infected with one M.O.I. of BoHV-4-EGFPΔTK. Infection was monitored under a
fluorescence microscopy at 24 and 48 hours after the infection. This experiment, along with others made under different condition, as indicated
into the text, was repeated three times with identical results.
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cible homologous recombination in a strain of BoHV-4
genome cloned as a Bacterial artificial chromosome
(BAC), pBAC-BoHV-4-A [12].
A targeting cassette (gB-KanaGalK-gB), excised from
pgB-KanaGalK-gB vector, containing the 2232 bp Kana/
GalK DNA stuffer double selecting cassette [21], flanked
by two BoHV-4 gB gene homology regions, was electro-
porated in SW102 E.coli containing pBAC-BoHV-4-A
genome and pBAC-BoHV-4-AΔgB-KanaGalK was ge-
nerated (Figure 4A). In the pBAC-BoHV-4-AΔgB-
KanaGalK genome, most of the gB ORF has been
replaced by Kana/GalK DNA stuffer double selection
cassette (Figure 4A). All recombinant selected clones
were shown to be authentic when analysed by PCR and
sequencing (data not shown), HindIII restriction enzyme
digestion and Southern hybridization (Figure 4B). In
order to obtain the revertant genome, pBAC-BoHV-4-
A-gBrevertant, a large DNA fragment obtained by PCR
from the BoHV-4-A genome, was electroporated in
SW102 E.coli containing the pBAC-BoHV-4-AΔgB-
KanaGalK genome. Following a double negative selec-
tion [12], several revertant clones were obtained as
showed by PCR, sequencing (data not shown), HindIII
restriction enzyme digestion and Southern hybridization
(Additional file 5: Figure S5A and B). The selected
clones’ stability was assessed by serially passaging over
25 days and analysis by HindIII restriction enzyme di-
gestion (Figure 4C and Additional file 5: Figure S5C). To
reconstitute infectious viruses, pBAC-BoHV-4-AΔgB-
KanaGalK and pBAC-BoHV-4-A-gBrevertant were electro-
porated into BEK or BEK/cre cells to excise the BAC
cassette. Surprisingly, the viable virus was obtained onlyfrom pBAC-BoHV-4-A-gBrevertant but not from pBAC-
BoHV-4-AΔgB-KanaGalK, in both BEK and BEK/cre
cells (Figure 5A). The deletion of gB rendered BoHV-4
unable to be reconstituted and productively replicated.
BoHV-4-A-gBrevertant growth characteristics were identi-
cal to the parental BoHV-4-A (Figure 5B).
VSVg could not complement BoHV-4 gB
Various attempts have been reported regarding gB
complementation in several gammaherpesviruses using
heterologous gB [20,22]. It was thus decided here to try
to complement gB with VSVg, which has been previously
shown to complement HSV-1 gB [20] and which is also
widely used to pseudo-type lentiviral vectors [23].
BoHV-4 gB ORF was deleted as was done for pBAC-
BoHV-4-AΔgB-KanaGalK, in BoHV-4-AΔL1.7-VSVG
(Additional file 6: Figure S6A, B and C). BoHV-4-
AΔL1.7-VSVG is a replicating competent attenuated
BoHV-4 expressing VSVg, where the VSVg expression cas-
sette is inserted into BoHV-4 L1.7 gene locus (Capocefalo
et al.; submitted paper). When pBAC-BoHV-4-AΔL1.7-
VSVGΔgB-KanaGalK was electroporated into BEK or
BEK/cre it was unable to reconstitute replicating viral
particles (data not shown), as was observed for the
deletion of gB from BoHV-4-A. This is a further dem-
onstration that BoHV-4 gB is essential and cannot
be complemented by a heterologous protein such as
VSVg.
Virus entry into host cells normally requires one
glycoprotein involved in cell binding and membrane
fusion, whereas herpesviruses use several viral glycopro-
teins to enter cells. Herpesvirus entry relies on a com-
plex multiprotein mechanism that is not yet well
Figure 4 BoHV-4 gB disruption. A) Overall strategy to delete a 1261 bp sequence from the ORF8 coding for gB, via heat inducible homologous
recombination. The 2232 bp Kana-GalK selectable DNA stuffer, flanked by ORF8 homologous regions, was introduced between positions 11640
and 12901 of the BoHV-4-A strain cloned as a BAC. The expected ORF8 locus (A, bottom) has an increased size of the HindIII fragment (5280
instead of 4314 bp), generated by HindIII restriction enzyme digestion. The diagrams here presented are not to scale. B) HindIII Restriction profile
and corresponding Southern Blotting of six representative targeted clones, compared to the untargeted control. Southern Blotting was
performed with a probe spanning Kana sequence and confirmed the above data. C) Clonal stability of the pBAC-BoHV-4-A-ΔgBKanaGalK in
Escherichia coli SW102 cells, passaged for 25 consecutive days and analyzed by HindIII digestion and agarose gel electrophoresis.
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tentially involved is widely studied, their action as a
complex, determining virus adhesion and cell entry has
not been fully clarified.
Gammaherpesviruses can infect different cell types in
a cell-dependent manner, as is the case for HHV-4,
which is able to infect B cells through the action of the
gp350, gp42, gB, gH and gL proteins, whereas it can
infect epithelial cells only with gB, gH and gL [24]. In
this complicated panorama, the role of gB is usually con-
served with respect to virus adhesion and fusion to the
host cells. Indeed, a gB homologue has been identified in
all Gammaherpesviruses [25].In MuHV-4, gB and gH are required for cell fusion
and the N-terminal half of gB is thought to be respon-
sible for the fusion, containing a putative fusion loop. A
change in pH drives the fusion and gB changes its state
from a pre-fusion state to a post-fusion one. Specific
mAbs directed against gB block membrane fusion, main-
tain gB in its post-fusion form, block the release of
virions from late endosomes [26], thus neutralizing
infection. Of the ten glycoproteins that have been
described in BoHV-4 [7], gB is the most abundant and
one of the major components of the virion. Similarly to
the majority of other gammaherpesviruses, like Equine
Herpesvirus 2 (EHV-2) and 5 (EHV-5) and MuHV-4,
Figure 5 A) Viral reconstitution. Representative fluorescence and phase contrast images (10X) of BoHV-4-A-ΔgBrevertant virus reconstitution
following pBAC-BoHV-4-A-ΔgBrevertant electroporation in BEK or BEK/cre cells. pBAC-BoHV-4-A-ΔgBKanaGalK was unable to reconstitute IRVPs after
electroporation in BEK or BEK/cre cells. B) Replication kinetics of BoHV-4-A-ΔgBrevertant compared with BoHV-4-A and BoHV-4-A-ΔgBKanaGalK. The
data presented are the means ± standard errors of triplicate measurements.
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[10,27]. The BoHV-4 ORF8 coding for gB is 2622 bp in
length and has a strict homology with HHV-4 gB, indi-
cating that these sequence similarities could correspond
to similar secondary and tertiary structures [3]. BoHV-4
gB transcript is unspliced and shows a typical TATA box
sequence positioned 80 nucleotides upstream of the first
ATG and a putative polyadenylation signal can be identi-
fied in 30 respect to the stop codon. BoHV-4 gB is an
heterodimeric glycoprotein, called gp6-gp10-gp17, with
an apparent molecular size of 150 kDa-120 kDa-51 kDa
respectively. gp10-gp17 are linked by disulfide bonds
and gp6 by non-covalent bonds and all these subunits
derive from the proteolitical cleavage of the gB gene
product [7]. BoHV-4 gB interaction with heparan-like
molecules present on host cell GAGs was previously
shown [8], demonstrating BoHV-4 gB contribution to
virus entry and fusion, but its direct necessity has not
yet been demonstrated.Conclusion
The present study may be considered the direct demon-
stration that gB is essential for BoHV-4 replication and
its deletion is not compatible with virus survival. More-
over, despite the structural similarity between BoHV-4
gB and VSVg proteins, gB substitution with VSVg is not
effective, emphasising the unique and specific role of gB
in BoHV-4 life cycle.Additional files
Additional file 1: Figure S1. A) Chimeric peptide gB/Fc sequence and
predicted amino-acid product. In black is highlighted the gB sequence, in
grey the putative protease site, RQKRS, and in sky blue the Fc sequence.
B) Representative contrast phase and fluorescence images of pWPI/gBFc
transfected HEK cells at 24 hours after transfection.
Additional file 2: Figure S2. A) Chimeric peptide gBtruncatedFc
sequence and predicted amino-acid product. In black is highlighted the
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B) Representative contrast phase and fluorescence images of pWPI/
gBtruncatedFc transfected HEK cells at 24 hours after transfection.
Additional file 3: Figure S3. A) Chimeric peptide gB/gD106 sequence
and predicted amino-acid product. In black is highlighted the gB
sequence, in grey the putative protease site, RQKRS, in yellow the gD106
sequence. B) Representative contrast phase and fluorescence images of
pWPI/gBgD106 transfected HEK cells at 24 hours after transfection.
Additional file 4: Figure S4. A) Chimeric peptide gBtruncated-gD106
sequence and predicted amino-acid product. In black is highlighted the
gB truncated sequence and in yellow the gD106 tag sequence.
B) Representative contrast phase and fluorescence images of pWPI/
gBtruncated-gD106 transfected HEK cells at 24 hours after transfection.
Additional file 5: Figure S5. A) Overall strategy to reconstitute the
ORF8 complete gB locus, via heat inducible homologous recombination.
The 2911 bp gB locus, amplified by PCR (between positions 10576 and
13487 of BoHV-4-A genome), was introduced to replace the 2232 bp
Kana-GalK selectable DNA stuffer, flanked by ORF8 homologous regions
in the BoHV-4-A ΔgBKanaGalK strain cloned as a BAC. The expected ORF8
locus (A, bottom) has decreased size of the HindIII fragment (4314
instead of 5280 bp), generated by HindIII restriction enzyme digestion
(diagram not on scale). B) HindIII restriction profile and corresponding
Southern Blotting of five representative targeted clones, compared to the
untargeted control. Southern Blotting was performed with a probe
spanning Kana sequence and confirmed the above data. C) Clonal
stability of the pBAC-BoHV-4-A-ΔgBrevertant in Escherichia coli SW102 cells,
passaged for 25 consecutive days and analyzed by HindIII digestion and
agarose gel electrophoresis.
Additional file 6: Figure S6. Overall strategy to delete a 1261 bp
sequence from the ORF8 codifying for gB, via heat inducible
homologous recombination. The 2232 bp Kana-GalK selectable DNA
stuffer, flanked by ORF8 homologous regions, was introduced between
positions 11640 and 12901 of the BoHV-4-AΔL1.7-eF-VSVG strain cloned
as a BAC. The expected ORF8 locus (A, bottom) has an increased size of
the HindIII fragment (5280 instead of 4314 bp), generated by HindIII
restriction enzyme digestion (diagram not on scale). B) HindIII Restriction
profile and corresponding Southern Blotting of six representative
targeted clones, compared to the untargeted control. Southern Blotting
was performed with a probe spanning Kana sequence and confirmed the
above data. C) Clonal stability of the pBAC-BoHV-4-A-ΔgBKanaGalK in
Escherichia coli SW102 cells, passaged for 30 consecutive days and
analyzed by HindIII digestion and agarose gel electrophoresis.
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